Hutchison China And AstraZeneca Partner For Kidney Cancer Study
LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said its research and development company Hutchison MediPharma Ltd and pharmaceuticals firm AstraZeneca PLC have initiated a global phase II study to evaluate the efficacy and safety of AZD6094, Hutchison's potent and highly selective c Read More